These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Modulation of serpin reaction through stabilization of transient intermediate by ligands bound to alpha-helix F. Komissarov AA; Zhou A; Declerck PJ J Biol Chem; 2007 Sep; 282(36):26306-15. PubMed ID: 17613529 [TBL] [Abstract][Full Text] [Related]
5. A fluorescent probe study of plasminogen activator inhibitor-1. Evidence for reactive center loop insertion and its role in the inhibitory mechanism. Shore JD; Day DE; Francis-Chmura AM; Verhamme I; Kvassman J; Lawrence DA; Ginsburg D J Biol Chem; 1995 Mar; 270(10):5395-8. PubMed ID: 7890653 [TBL] [Abstract][Full Text] [Related]
6. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1. Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886 [TBL] [Abstract][Full Text] [Related]
7. A serpin-induced extensive proteolytic susceptibility of urokinase-type plasminogen activator implicates distortion of the proteinase substrate-binding pocket and oxyanion hole in the serpin inhibitory mechanism. Egelund R; Petersen TE; Andreasen PA Eur J Biochem; 2001 Feb; 268(3):673-85. PubMed ID: 11168406 [TBL] [Abstract][Full Text] [Related]
8. Mutation of the highly conserved tryptophan in the serpin breach region alters the inhibitory mechanism of plasminogen activator inhibitor-1. Blouse GE; Perron MJ; Kvassman JO; Yunus S; Thompson JH; Betts RL; Lutter LC; Shore JD Biochemistry; 2003 Oct; 42(42):12260-72. PubMed ID: 14567688 [TBL] [Abstract][Full Text] [Related]
9. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954 [TBL] [Abstract][Full Text] [Related]
10. A urokinase-type plasminogen activator-inhibiting cyclic peptide with an unusual P2 residue and an extended protease binding surface demonstrates new modalities for enzyme inhibition. Hansen M; Wind T; Blouse GE; Christensen A; Petersen HH; Kjelgaard S; Mathiasen L; Holtet TL; Andreasen PA J Biol Chem; 2005 Nov; 280(46):38424-37. PubMed ID: 16141208 [TBL] [Abstract][Full Text] [Related]
11. Protonation state of a single histidine residue contributes significantly to the kinetics of the reaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator. Komissarov AA; Declerck PJ; Shore JD J Biol Chem; 2004 May; 279(22):23007-13. PubMed ID: 15033993 [TBL] [Abstract][Full Text] [Related]
12. Maspin binds to urokinase-type and tissue-type plasminogen activator through exosite-exosite interactions. Al-Ayyoubi M; Schwartz BS; Gettins PG J Biol Chem; 2007 Jul; 282(27):19502-9. PubMed ID: 17510061 [TBL] [Abstract][Full Text] [Related]
13. Type-1 plasminogen-activator inhibitor -- conformational differences between latent, active, reactive-centre-cleaved and plasminogen-activator-complexed forms, as probed by proteolytic susceptibility. Egelund R; Schousboe SL; Sottrup-Jensen L; Rodenburg KW; Andreasen PA Eur J Biochem; 1997 Sep; 248(3):775-85. PubMed ID: 9342229 [TBL] [Abstract][Full Text] [Related]
14. Binding of urokinase-type plasminogen activator-plasminogen activator inhibitor-1 complex to the endocytosis receptors alpha2-macroglobulin receptor/low-density lipoprotein receptor-related protein and very-low-density lipoprotein receptor involves basic residues in the inhibitor. Rodenburg KW; Kjoller L; Petersen HH; Andreasen PA Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):55-63. PubMed ID: 9405275 [TBL] [Abstract][Full Text] [Related]
15. Distinct encounter complexes of PAI-1 with plasminogen activators and vitronectin revealed by changes in the conformation and dynamics of the reactive center loop. Qureshi T; Goswami S; McClintock CS; Ramsey MT; Peterson CB Protein Sci; 2016 Feb; 25(2):499-510. PubMed ID: 26548921 [TBL] [Abstract][Full Text] [Related]
16. Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1. Rezaie AR Biochemistry; 1998 Sep; 37(38):13138-42. PubMed ID: 9748320 [TBL] [Abstract][Full Text] [Related]
17. A truncated plasminogen activator inhibitor-1 protein induces and inhibits angiostatin (kringles 1-3), a plasminogen cleavage product. Mulligan-Kehoe MJ; Wagner R; Wieland C; Powell R J Biol Chem; 2001 Mar; 276(11):8588-96. PubMed ID: 11113116 [TBL] [Abstract][Full Text] [Related]
18. A concerted structural transition in the plasminogen activator inhibitor-1 mechanism of inhibition. Blouse GE; Perron MJ; Thompson JH; Day DE; Link CA; Shore JD Biochemistry; 2002 Oct; 41(40):11997-2009. PubMed ID: 12356300 [TBL] [Abstract][Full Text] [Related]
19. Interaction between the P14 residue and strand 2 of beta-sheet B is critical for reactive center loop insertion in plasminogen activator inhibitor-2. Saunders DN; Jankova L; Harrop SJ; Curmi PM; Gould AR; Ranson M; Baker MS J Biol Chem; 2001 Nov; 276(46):43383-9. PubMed ID: 11555638 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms of conversion of plasminogen activator inhibitor 1 from a suicide inhibitor to a substrate by monoclonal antibodies. Komissarov AA; Declerck PJ; Shore JD J Biol Chem; 2002 Nov; 277(46):43858-65. PubMed ID: 12223472 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]